IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 22, 2019

Primary Completion Date

October 31, 2023

Study Completion Date

January 31, 2026

Conditions
Lymphoma, T-CellLymphoma, T-Cell, CutaneousMycosis Fungoides/Sezary Syndrome
Interventions
BIOLOGICAL

IPH4102

Patients will receive a flat dose of 750mg

Trial Locations (53)

1070

Institut Jules Bordet, Brussels

1090

Medizinische Universitaet Wien, Vienna

3000

UZ Leuven - campus Gasthuisberg, Leuven

4000

Centre Hospitalier Universitaire (CHU) de Liege, Liège

10032

Columbia University Department of Dermatology, New York

10115

Charite - Universitaetsmedizin Berlin, Berlin

10126

Universita di Torino, Ospedale le Molinette, Turin

13009

Institut Paoli-Calmettes, Marseille

14450

Universal Dermatology, PLLC68, Fairport

15208

University of Pittsburgh School of Medicine, Pittsburgh

19104

University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

22031

Inova Health Care Services, Fairfax

24105

Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel

25123

ASST degli Spedali Civili di Brescia, Brescia

28041

Hospital Universitario 12 de Octubre, Madrid

31100

IUCT Oncopôle, Toulouse

32429

Johannes Wesling Klinikum Minden, Minden

33075

CHU de Bordeaux Saint André, Bordeaux

33612

Moffitt Cancer Center, Tampa

University of South Florida, Tampa

34095

CHRU de Montpellier - Hopital Saint Eloi, Montpellier

35294

University of Alabama at Birmingham, Birmingham

37007

Hospital Clinico Universitario de Salamanca, Salamanca

37170

CHRU de Tours, Hôpital Trousseau, Chambray-lès-Tours

40138

"Institute of Hematology Seràgnoli, Univeristy of Bologna", Bologna

44791

Ruhr-University Bochum, Bochum

46014

Consorci Hospital General Universitari de Valencia Servicio de Dermatología, Valencia

46026

Hospital Universitari i Politecnic La Fe, Valencia

48149

Universitaetsklinikum Muenster, Münster

59037

CHRU de Lille - Hopital Claude Huriez, Lille

60590

Universitätsklinikum Frankfurt, Frankfurt

60611

Northwestern University The Feinberg School of Medicine, Chicago

63110

Washington University School of Medicine, St Louis

68167

Universitaetsmedizin Mannheim GmbH, Mannheim

69310

Centre Hospitalier Lyon-Sud, Lyon

75010

Hôpital Saint-Louis, Paris

76031

Hôpital Charles Nicolle-CHU de Rouen Clinique Dermatologie, Rouen

90095

University of California, Los Angeles (UCLA) - Medical Center, Los Angeles

92868

Irvine Medical Center, Orange

94010

CHU Henri Mondor, Créteil

94305

Stanford University, Stanford

02215

Dana-Farber Cancer Institute, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

77030-4009

MD Anderson Cancer Center, Houston

A-8036

Universitätsklinik für Dermatologie Medizinische Universität Graz, Graz

06120

Universitaetsklinikum Halle (Saale), Halle

00167

Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Roma

80-214

Uniwersyteckie Centrum Kliniczne, Klinika Dermatologii, Wenerologii i Alergologii ul. Smoluchowskiego 17, Gdansk

60-185

CET Centrum Medyczne Pratia Poznan ul. Poznanska 14, Skorzewo

02-781

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Ukladu Chlonnego, Warsaw

08003

Hospital del Mar, Barcelona

08036

Hospital Clinic Barcelona, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Innate Pharma

INDUSTRY